Nanosonics Share Price and Company Fundamentals
Last traded: Last Friday at 5:10 AM
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Key Metrics
PE ratio
-
PB ratio
10.06
Dividend yield
0.00%
Beta
1.63
Market cap
-
Enterprise value
-
Company profile
| Primary activities | The Company is focused on the research, development, and commercialisation of innovative technologies in infection control and decontamination. The Company's strategic goal is to establish itself as a recognised global leader in economical, safe, low or |
|---|---|
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
| Full time employees | 425 |
| Website | https://www.nanosonics.com.au |
| Mailing address | Building A Level 1 7-11 Talavera Road Macquarie Park NSW 2113 Australia |
| Phone / Fax | 61 2 8063 1600 / 61 2 9418 3743 |
| Share registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED |
Dividends
More: Nanosonics Dividend history, yield and payout ratio
Dividend yield
0.00%
Dividend amount
$0.00
Payout ratio
0.00%
Nanosonics paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.NAN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
NAN's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Dec 2022, following are the company executives and directors listed on Nanosonics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Michael C. Kavanagh BSc, M.B.A. | CEO, Pres, MD & Exec. Director | 1.03M | |
| Mr. McGregor Grant BEc, C.A., CA, FCIS, GAICD | CFO & Company Sec. | 521.23k | |
| Mr. Rod Lopez M.B.A. | Chief Operating Officer | 510.76k | |
| Dr. Steven Farrugia BE, Ph.D. | Chief Technology Officer | 517.7k | |
| Mr. David N. Morris | Chief Strategy Officer & Regional Pres Asia Pacific | 550.43k | |
| Matthew Carbines B.Com., L.L.B. | Gen. Counsel | ||
| Mr. Matthew Lipscombe B.E., B.Sc., M.B.A. | Chief Marketing Officer | ||
| Ms. Jodi Sampson | Chief People & Culture Officer | ||
| Mr. Vincent Wang | Head of Global Customer Support & Technical Services | ||
| Mr. Keith Koby | Sr. VP of Sales - North America |
Profitability and management effectiveness
Profit margin
3.11%
Operating margin
1.53%
Return on assets
0.66%
Return on equity
2.73%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Nanosonics is and its enterprise value is .
The NAN's stocks Beta value is 1.63 making it 63% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Nanosonics (NAN)
- Ansell (ANN)
- Cochlear (COH)
- Fisher & Paykel Healthcare Corporation (FPH)
- Estia Health (EHE)
- Healius (HLS)
- Pro Medicus (PME)
- Resmed Inc (RMD)
- Ramsay Health Care (RHC)
- Polynovo (PNV)
- Sonic Healthcare (SHL)
Nanosonics (ASX:NAN) Frequently Asked Questions
1. What is Nanosonics's Stock Symbol?
Nanosonics trades on ASX under the ticker symbol "NAN".
2. What is Nanosonics's stock price today?
One share of NAN stock can currently be purchased for approximately $4.86.
3. How can I contact Nanosonics?
Nanosonics's mailing address is Building A Level 1 7-11 Talavera Road Macquarie Park NSW 2113 Australia. The company can be reached via phone at 61 2 8063 1600.
4. What is Nanosonics's official website?
The official website of Nanosonics is https://www.nanosonics.com.au.
5. Which share registry manages Nanosonics's stock?
Nanosonics's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.